Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784)
10/2000
10/18/2000EP1044001A1 Integrin receptor antagonists
10/18/2000EP1044000A1 Combination therapy for the treatment of aids
10/18/2000EP1043998A1 USE OF PYRAZOLO 3,4-b] PYRIDINE AS CYCLIN DEPENDENT KINASE INHIBITORS
10/18/2000EP1043990A1 Pyronin antibacterials, process and novel intermediates thereto
10/18/2000EP1043978A1 Phospholipid-coated microcrystals for the sustained release of pharmacologically active compounds and methods of their manufacture and use
10/18/2000EP1043974A1 Liposomes containing multiple branch peptide constructions for use against human immunodeficiency virus
10/18/2000EP0726704B1 Method of introducing material into eggs during early embryonic development
10/18/2000EP0603251B1 1-substituted 1h-imidazo(4,5-c)quinolin-4-amines; intermediate and pharmaceutical compositions
10/18/2000CN1270635A Immune responses against HPV antigens elicited by compositions comprising an HPV antigen and a stress protein or an expression vector capable of expression of these protein
10/18/2000CN1270594A Process for producing 3-cephem compounds
10/18/2000CN1270524A Cationic polymers as toxin-binding agents
10/18/2000CN1270517A Antimicrobials
10/18/2000CN1270172A Preparation of d4T from 5-methyl uridine
10/18/2000CN1270062A Glycobiazole metal salt as synergist for radiotherapy or chemicotherapy and its preparing process and application
10/18/2000CN1270061A 弯曲菌疫苗 Campylobacter vaccine
10/18/2000CN1270033A Gel composition for treating pulmonary tuberculosis cavity difficult to cure it
10/18/2000CN1057533C Method for producing clostridium perfringers vaccines
10/18/2000CN1057520C N, N'-substituted imidocarbonimidic diaides derivative from hydroxylamines, its medicinal composition and uses
10/18/2000CN1057451C Children coryza medicine and preparing method
10/17/2000US6133460 Have primary amino substitutions on the 3-, 4-, 5-, and 8-positions of the psoralen which permit binding to nucleic acid of pathogens; conditions that photoactivate these psoralens result in inactivation of pathogens which contain nucleic acid
10/17/2000US6133418 Synthetic peptide inhibitors of HIV transmission
10/17/2000US6133284 Excellent bactericidal properties and oral absorption; infections from gramnegative and -positive bacteria; intestinal absorption, metabolic stability; side effect reduction; nonphototoxicity and noncytotoxicity
10/17/2000US6133270 Isothiazolones and pharmaceutical formulations
10/17/2000US6133260 Use of 7-(2-oxa-5,8-diazabicyclo[4.3.0]non-8-yl)-quinolone carboxylic acid and naphthyridon carboxylic acid derivatives for the treatment of Helicobacter pylori infections and associated gastroduodenal diseases
10/17/2000US6133240 Tetrahydronapthalene derivatives and their therapeutic use
10/17/2000US6133024 Recombinant vector which codes for an rna capable of forming a triple helix with target nucleic acid; for transcription of the rna in target cells
10/17/2000US6133010 Chlamysin B antibacterial protein, a protein gene for and an expression system for same
10/17/2000US6133006 Nucleotide sequence coding an enzmatic polypeptide associated with signal transduction; for the diagnosis and treatment of osteoporosis, inflammation, skin disorders, asthma, nervous system disorders, cancer, eating disorders and infections
10/17/2000US6132966 Enzymatic nucleic acid which specifically prevents viral replication; for the treatment of transformed hepatocytes and suppression of viral infection humans, animals and primates
10/17/2000US6132962 Plasmid coding ribozyme; for the prevention of viral infection
10/17/2000US6132775 Treating gram-negative bacterial infections in mammals by administering purified, isolated polypeptide having bactericidal/permeability-increasing protein activity
10/17/2000US6132768 Oral pharmaceutical composition with delayed release of active ingredient for reversible proton pump inhibitors
10/17/2000US6132756 Use of sandalwood oil for the prevention and treatment of warts, skin blemishes and other viral-induced tumors
10/17/2000US6132750 Particles of cross-linked proteins and polysaccharides with hydroxamic groups for chelating metals and their uses notably in cosmetics
10/17/2000US6132733 Ringworm vaccine
10/17/2000US6132732 Parvovirus capsids
10/17/2000US6132725 Reverse transcriptase inhibitor
10/17/2000US6132723 Oligosaccharide hapten covalently coupled to carrier protein
10/17/2000US6132718 Using a vaccine comprising antibodies and anti-idiotype antibodies that mimic an epitope of antigen that is associated with a tumor or infectious agent.
10/17/2000US6132715 Method of inhibiting biosynthesis of tumor necrosis factor
10/17/2000US6132709 Administering a fusobacterium necrophorum bacterin
10/17/2000US6131226 1,4-dihydropyridine compounds as bradykinin antagonists
10/17/2000CA2178752C N-terminally chemically modified protein compositions and methods
10/17/2000CA2177357C Pna-dna-pna chimeric macromolecules
10/17/2000CA2148071C Method of administering azithromycin
10/17/2000CA2104899C Antibodies to plasmodium falciparum
10/17/2000CA2009221C Spray preparations for respiratory tract infections
10/17/2000CA2001205C Antimicrobial quinolonyl lactams
10/12/2000WO2000060357A1 Tandem immuno-assay for cancer
10/12/2000WO2000060082A2 Vesicle associated proteins
10/12/2000WO2000060080A2 Molecules of the immune system
10/12/2000WO2000060075A1 Novel proteins, gene encoding the same and method of utilization thereof
10/12/2000WO2000060066A1 Protein-protein from s. cerevisiae and methods of using same
10/12/2000WO2000060050A2 Recombinant influenza viruses for vaccines and gene therapy
10/12/2000WO2000059944A1 A monoclonal antibody against estrogen stimulated leucine aminopeptidase
10/12/2000WO2000059937A1 Silver-containing complex protein and antibacterial/antifungal agents and antibacterial/antifungal papers with the use of the same
10/12/2000WO2000059929A1 Macrocyclic peptides active against the hepatitis c virus
10/12/2000WO2000059928A1 Chemokine-derived synthetic peptides
10/12/2000WO2000059904A2 Compounds and methods to treat cardiac failure and other disorders
10/12/2000WO2000059901A1 Substituted 1,4-dihydroindeno[1,2-c]pyrazoles as inhibitors of tyrosine kinase
10/12/2000WO2000059899A1 Novel lipoic acid derivatives, their preparation, and pharmaceutical compositions containing them
10/12/2000WO2000059884A1 Pharmaceutically active compounds and methods of use thereof
10/12/2000WO2000059875A2 Novel inhibitors of formation of advanced glycation endproducts (age's)
10/12/2000WO2000059874A1 NOVEL AMIDE DERIVATIVES AS INHIBITORS OF MATRIX METALLOPROTEINASES, TNF-α, AND AGGRECANASE
10/12/2000WO2000059867A1 Hydroxyphenyl derivatives with hiv integrase inhibitory properties
10/12/2000WO2000059543A1 Over-coated chewing gum formulations
10/12/2000WO2000059539A1 Method and means for treating post-polio syndrome
10/12/2000WO2000059534A1 Method and compositions for preventing or reducing hiv infection by use of inhibitors for leucine aminopeptidase
10/12/2000WO2000059527A1 Antimicrobial amino acid sequences derived from alpha-melanocyte-stimulating hormone
10/12/2000WO2000059524A1 Antiviral composition
10/12/2000WO2000059515A2 Immunomodulating polymers
10/12/2000WO2000059511A1 Use of tianeptin in the production of medicaments to treat neurodegenerative pathologies
10/12/2000WO2000059503A1 Pyrrolidine modulators of chemokine receptor activity
10/12/2000WO2000059502A1 Pyrrolidine modulators of chemokine receptor activity
10/12/2000WO2000059498A1 Pyrrolidine modulators of chemokine receptor activity
10/12/2000WO2000059497A1 Pyrrolidine modulators of chemokine receptor activity
10/12/2000WO2000059484A2 Use of arylalkanoylpyridazines
10/12/2000WO2000059483A2 Transdermal drug delivery devices comprising a polyurethane drug reservoir
10/12/2000WO2000059481A1 PHARMACEUTICAL DOSAGE FORM FOR PULSATILE DELIVERY OF d-threo-METHYLPHENIDATE AND A SECOND CNS STIMULANT
10/12/2000WO2000059479A1 Pharmaceutical dosage form for pulsatile delivery of methylphenidate
10/12/2000WO2000059472A1 Propofol compositions containing preservative additives
10/12/2000WO2000059469A2 Endodontic fibers and methods of use therefor
10/12/2000WO2000059468A1 Drinkable pharmaceutical solution
10/12/2000WO2000059448A2 Association of no-synthase inhibitor(s) and metabolic antioxidant(s)
10/12/2000WO2000037494A3 Chlamydia trachomatis antigens
10/12/2000WO2000034445A3 Live attenuated venezuelan equine encephalitis vaccine
10/12/2000WO2000032227A3 Ordered molecular presentation of antigens, method of preparation and use
10/12/2000WO2000027196B1 Use of gm-csf to inhibit development of drug resistance in hiv+ patients
10/12/2000WO2000025722A3 ENHANCED VACCINES COMPRISING SELF AND NON-SELF IgE PORTIONS OR DIMERIC ANTIGENS
10/12/2000WO2000002522A3 Anthrax vaccine
10/12/2000WO1999051188A9 A polypeptide comprising the amino acid of an n-terminal choline binding protein a truncate, vaccine derived therefrom and uses thereof
10/12/2000WO1999041376A8 Retinoblastoma protein complexes and retinoblastoma interacting proteins
10/12/2000DE19916176A1 Neue essentielle bakterielle Gene und ihre Proteine New essential bacterial genes and their proteins
10/12/2000DE19915364A1 Verwendung von Arylalkanoylpyridazinen Use of Arylalkanoylpyridazinen
10/12/2000CA2373717A1 Pyrrolidine modulators of chemokine receptor activity
10/12/2000CA2369071A1 Novel lipoic acid derivatives, their preparation, pharmaceutical use and pharmaceutical compositions cantaining them
10/12/2000CA2368686A1 Substituted 1,4-dihydroindeno[1,2-c]pyrazoles as inhibitors of tyrosine kinase
10/12/2000CA2368387A1 Antimicrobial amino acid sequences derived from alpha-melanocyte-stimulating hormone
10/12/2000CA2368367A1 Pharmaceutical dosage form for pulsatile delivery of methylphenidate
10/12/2000CA2367378A1 Molecules of the immune system
1 ... 1434 1435 1436 1437 1438 1439 1440 1441 1442 1443 1444 1445 1446 1447 1448 1449 1450 1451 1452 1453 1454 ... 1798